Expert Review of Vaccines

Moving influenza vaccines forward
pp. 375-377(3)
Authors: Sambhara, Suryaprakash; Stephenson, Iain

News in brief
pp. 379-381(3)

Seasonal influenza vaccines: evolutions and future trends
pp. 383-389(7)
Authors: Monto, Arnold S; Ohmit, Suzanne E

Progress with human H5N1 vaccines: a perspective from industry
pp. 391-400(10)
Authors: Palache, Bram; Krause, Ryoko

Current status and progress of prepandemic and pandemic influenza vaccine development
pp. 401-423(23)
Authors: Leroux-Roels, Isabel; Leroux-Roels, Geert

Increasing influenza vaccination coverage in recommended population groups in Europe
pp. 425-433(9)
Authors: Blank, Patricia R; Szucs, Thomas D

Influenza virus-like particle vaccines
pp. 435-445(11)
Author: Haynes, Joel R

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
pp. 447-454(8)
Authors: Rimmelzwaan, Guus F; Sutter, Gerd

Baculovirus vector as a delivery vehicle for influenza vaccines
pp. 455-467(13)
Authors: He, Fang; Madhan, Selvaraj; Kwang, Jimmy

Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines
pp. 469-481(13)
Authors: Tang, De-chu C; Zhang, Jianfeng; Toro, Haroldo; Shi, Zhongkai; Van Kampen, Kent R

Emulsion-based adjuvants for influenza vaccines
pp. 483-492(10)
Authors: Vogel, Frederick R; Caillet, Catherine; Kusters, Inca C; Haensler, Jean

Using plant cells as influenza vaccine substrates
pp. 493-498(6)
Authors: Chichester, Jessica A; Haaheim, Lars R; Yusibov, Vidadi

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
pp. 499-508(10)
Authors: Schotsaert, Michael; De Filette, Marina; Fiers, Walter; Saelens, Xavier

Acknowledgements
pp. 513-513(1)

Acknowledgements
pp. 513-513(1)